One Ascent Financial Services LLC Sage Therapeutics, Inc. Transaction History

One Ascent Financial Services LLC

  • $718 Million
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Jul 21, 2020
SELL
$25.95 - $43.15 $195,429 - $324,962
-7,531 Closed
0 $0
Q1 2020

Apr 14, 2020
BUY
$26.15 - $77.24 $196,935 - $581,694
7,531 New
7,531 $216,000
Q3 2019

Nov 15, 2019
SELL
$140.29 - $189.96 $309,479 - $419,051
-2,206 Closed
0 $0
Q2 2019

Aug 15, 2019
BUY
$157.85 - $183.09 $348,217 - $403,896
2,206 New
2,206 $404,000

Others Institutions Holding SAGE

# of Institutions
217
Shares Held
48.2M
Call Options Held
854K
Put Options Held
195K
View Full List

About Sage Therapeutics, Inc.

SAGE Quotes by TradingView
  • Ticker SAGE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,422,300
  • Market Cap $428M
  • Description
  • Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...
More about SAGE
Track This Portfolio

Track One Ascent Financial Services LLC Portfolio

Follow One Ascent Financial Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of One Ascent Financial Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on One Ascent Financial Services LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email